Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia. [electronic resource]
Producer: 20190702Description: 1222-1225 p. digitalISSN:- 1537-6591
- Aged, 80 and over
- Amino Acid Sequence
- Antiprotozoal Agents -- therapeutic use
- Atovaquone -- therapeutic use
- Azithromycin -- therapeutic use
- Babesia microti -- drug effects
- Babesiosis -- drug therapy
- Drug Resistance -- drug effects
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- parasitology
- Male
- Rituximab -- therapeutic use
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.